DTC Defence Therapeutics Inc

0.518

-0.01 (-1.89%)

31 Jul 2024 - Closed

Realtime Data

Share Name	Share Symbol	Market	Type
Defence Therapeutics Inc	TG:DTC	Tradegate	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.01	-1.89%	0.518	0.50	0.536	0.548	0.486	0.548	27,920	22:50:01

Domtar announces fourth quarter and full year 2005 financial results

01/02/2006 1:32pm

PR Newswire (US)

Defence Therapeutics (TG:DTC)
Historical Stock Chart

From Aug 2019 to Aug 2024

Click Here for more Defence Therapeutics Charts.

DTC (TSX,NYSE) MONTREAL, Feb. 1 /PRNewswire-FirstCall/ -- Domtar Inc. announced today a net loss of $348 million ($1.51 per common share) in the fourth quarter of 2005 compared to a net loss of $26 million ($0.11 per common share) in the fourth quarter of 2004 and a net loss of $52 million ($0.23 per common share) in the third quarter of 2005. For the full year of 2005, Domtar recorded a net loss of $388 million ($1.69 per common share) compared to a net loss of $42 million ($0.19 per common share) in 2004.